A California jury let the makers of Botox off the hook Tuesday in the death of a 7-year-old girl with cerebral palsy. But the jury never considered whether injections the girl received contributed to her death, instead finding that Botox carried sufficient warning labels.

The ruling is win for drug maker Allergan Inc. in what is believed to be the first case to come to trial alleging that Botox use led to death. But it could be short-lived, as more cases are in cue for trial across the country.

This case centered on the death of 7-year-old Kristen Spears who was given Botox injections to ease symptoms of cerebral palsy. The girl’s mother, Dee, alleged that an overdose of the drug weakened her daughter’s muscles leading to pneumonia and respiratory failure.

Advertisement - Continue Reading Below

At trial, Spears’ attorney argued that Allergan did not properly warn doctors — including Kristen’s — of the harmful effects Botox could have.

The jury, however, found that Allergan’s warnings were adequate, but did not weigh in on whether the drug contributed to the girl’s death, reports the Los Angeles Times. To read more click here.

Botox is commonly used to remove wrinkles. It is not approved in the United States for the treatment of cerebral palsy, though it is approved for this use in some other countries.

Last year, the Food and Drug Administration issued a warning about the use of Botox in those with cerebral palsy amid reports of hospitalization and death in some children. But more recently two groups of neurologists published guidelines saying that despite some risks, Botox injections are generally safe and effective for treating kids and adolescents with cerebral palsy.